These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8520342)

  • 1. Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet.
    Pal B; Hutchinson A; Bhattacharya A; Ralston A
    BMJ; 1995 Dec; 311(7018):1486-7. PubMed ID: 8520342
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoporphyria induced by nabumetone.
    Krischer J; Scolari F; Kondo-Oestreicher M; Vollenweider-Roten S; Saurat JH; Pechère M
    J Am Acad Dermatol; 1999 Mar; 40(3):492-3. PubMed ID: 10071328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabumetone-associated pseudoporphyria.
    Antony F; Layton AM
    Br J Dermatol; 2000 May; 142(5):1067-9. PubMed ID: 10809892
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary fibrosis associated with nabumetone.
    Morice A; Atherton A; Gleeson F; Stewart S
    Postgrad Med J; 1991 Nov; 67(793):1021-2. PubMed ID: 1775411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoporphyria caused by nabumetone.
    Varma S; Lanigan SW
    Br J Dermatol; 1998 Mar; 138(3):549-50. PubMed ID: 9580823
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs.
    Meggitt SJ; Farr PM
    Br J Dermatol; 1999 Sep; 141(3):591-2. PubMed ID: 10583088
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe immediate reaction to nabumetone.
    Gonzalo-Garijo MA; Cordobés-Duran C; Lamilla-Yerga AM; Moreno-Gastón I
    J Investig Allergol Clin Immunol; 2007; 17(4):274-6. PubMed ID: 17694703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypereosinophilic syndrome: endomyocardial fibrosis.
    Pitt M; Davies MK; Brady AJ
    Heart; 1996 Oct; 76(4):377-8. PubMed ID: 8983691
    [No Abstract]   [Full Text] [Related]  

  • 9. GI bleeding associated with nabumetone.
    Voss GD; Schweitzer P
    Am J Hosp Pharm; 1994 Oct; 51(19):2506, 2508. PubMed ID: 7847412
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of nabumetone induced pseudoporphyria.
    Checketts SR; Morgan GJ
    J Rheumatol; 1999 Dec; 26(12):2703-5. PubMed ID: 10606389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nabumetone-associated interstitial nephritis.
    Blackwell E; Loughlin K; Dumler F; Smythe M
    Pharmacotherapy; 1995; 15(5):669-72. PubMed ID: 8570441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of nabumetone: a pilot in vitro study showing absence of injury to articular cartilage.
    Giordano N; Senesi M; Battisti E; Gonnelli S; Franci B; Campagna MS; Mattii G; Palumbo F; Gennari C
    Int J Tissue React; 1996; 18(4-6):105-8. PubMed ID: 9195245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed drug eruption due to nabumetone in a patient with previous fixed drug eruptions due to naproxen.
    Pérez-Calderón R; Gonzalo-Garijo MA; Pérez-Rangel I; Sánchez-Vega S; Zambonino MA
    J Investig Allergol Clin Immunol; 2011; 21(2):153-4. PubMed ID: 21462807
    [No Abstract]   [Full Text] [Related]  

  • 14. An overview of the long-term safety experience of nabumetone.
    Willkens RF
    Drugs; 1990; 40 Suppl 5():34-7. PubMed ID: 2081490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nabumetone induced pseudoporphyria in childhood.
    Cron RQ; Finkel TH
    J Rheumatol; 2000 Jul; 27(7):1817-8. PubMed ID: 10914877
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis].
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.
    Roth SH; Tindall EA; Jain AK; McMahon FG; April PA; Bockow BI; Cohen SB; Fleischmann RM
    Arch Intern Med; 1993 Nov; 153(22):2565-71. PubMed ID: 8239849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.
    Confino-Cohen R; Goldberg A
    Allergy Asthma Proc; 2003; 24(4):281-4. PubMed ID: 12974196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.